Michael Ybarra, MD, FACEP, FAPCR, is Vice President and Chief Medical Officer at the Pharmaceutical Research and Manufacturers of America (PhRMA).
As an organization, PhRMA advocates for public policies that support the innovative biopharmaceutical ecosystem. Dr. Ybarra manages teams responsible for coalition building, stakeholder engagement, and strategic partnerships domestically and internationally in support of PhRMA’s public policy priorities. That includes areas such as pandemic preparedness, industry’s COVID-19 response, and addressing the threat of antimicrobial resistance. In addition, his team advocates on issues related to implementation of the Inflation Reduction Act, Medicare Parts B, D, the 340B drug discount program, and the Food and Drug Administration. He engages with organizations across the health care ecosystem, including patient advocacy, civil rights, and multicultural organizations, as well as medical societies.
Dr. Ybarra is an emergency physician and a graduate of Stanford University and Georgetown University School of Medicine, where he also completed his residency training. He is an Assistant Professor of Emergency Medicine at Georgetown University School of Medicine where he continues to see patients in the emergency department while mentoring medical students, residents, and health policy fellows. For nearly a decade, he was an active leader in the American Academy of Emergency Medicine (AAEM), serving on the Board of Directors, Director of the Young Physicians Section, and President of the Resident and Student Association. He currently sits on the board of the Society for Women’s Health Research (SWHR) and the Academy of Physicians in Clinical Research (APCR). He is the alternate delegate for the APCR in the American Medical Association House of Delegates. He is also the author of several peer review publications and book chapters.